Avopef
etoposide
- Strength
- 500 mg/25mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Avyxa Pharma, LLC
Etoposide
Listed by BluePoint Laboratories
- Strength
- 20 mg/mL
- Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Class
- Topoisomerase Inhibitor
What it contains
- Etoposide 20 mg/mL
FDA record
| Dosage form | Injection, Solution, Concentrate |
|---|---|
| Route | Intravenous |
| Drug class | Topoisomerase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 68001-682 |
| FDA application | ANDA074529 |
| RxNorm concept | 310248 |
| Package sizes listed | 1 |
| Marketed since | December 2025 |
Other products containing Etoposide
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Avopef
etoposide
- Strength
- 100 mg/5mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Avyxa Pharma, LLC
ETOPOPHOS
etoposide phosphate
- Strength
- 100 mg/1
- Form
- Injection, Powder, Lyophilized, For Solution
- Class
- Topoisomerase Inhibitor
H2-Pharma, LLC
Etoposide
- Strength
- 50 mg/1
- Form
- Capsule
- Class
- Topoisomerase Inhibitor
Mylan Pharmaceuticals Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Accord Healthcare Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Hikma Pharmaceuticals USA Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection, Solution, Concentrate
- Class
- Topoisomerase Inhibitor
Meitheal Pharmaceuticals Inc.
Etoposide
- Strength
- 20 mg/mL
- Form
- Injection
- Class
- Topoisomerase Inhibitor
Hikma Pharmaceuticals USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.